|
|
|
|
| LEADER |
00000cam a22000004a 4500 |
| 001 |
p1091607 |
| 005 |
20230112152814.0 |
| 008 |
090901t20102010njua b 001 0 eng |
| 010 |
|
|
|a 2009036489
|
| 016 |
7 |
|
|a 101514345
|2 DNLM
|
| 020 |
|
|
|a 9780470041383 (cloth)
|
| 020 |
|
|
|a 0470041382 (cloth)
|
| 029 |
1 |
|
|a NLM
|b 101514345
|
| 029 |
1 |
|
|a AU@
|b 000044694812
|
| 029 |
1 |
|
|a IG#
|b 9780470041383
|
| 035 |
|
|
|a (OCoLC)326670293
|
| 040 |
|
|
|a DNLM/DLC
|c DLC
|d NLM
|d BTCTA
|d C#P
|d YDXCP
|d SDB
|d IG#
|d UtOrBLW
|
| 042 |
|
|
|a pcc
|
| 049 |
|
|
|a MPAA
|
| 050 |
0 |
0 |
|a RS425
|b .L54 2010
|
| 060 |
0 |
0 |
|a 2010 A-403
|
| 060 |
1 |
0 |
|a QV 744
|b L723 2010
|
| 082 |
0 |
0 |
|a 615/.19
|2 22
|
| 245 |
0 |
0 |
|a Ligand-binding assays :
|b development, validation, and implementation in the drug development arena /
|c edited by Masood N. Khan, John W.A. Findlay.
|
| 264 |
|
1 |
|a Hoboken, N.J. :
|b Wiley,
|c [2010]
|
| 264 |
|
4 |
|c ©2010
|
| 300 |
|
|
|a xvi, 403 pages :
|b illustrations ;
|c 25 cm
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Introduction and historical perspective / John W.A. Findlay and Masood N. Khan -- Ligand-binding assays to support disposition studies of macromolecular therapeutics / Marian M. Kelley, Marjorie A. Mohler, and John W.A. Findlay -- Development of ligand-binding assays for drug development support / Masood Khan ... [et al.] -- Validation of ligand-binding assays to support pharmacokinetic assessments of biotherapeutics / Binodh Desilva and Ronald R. Bowsher -- Statistical considerations in the validation of ligand-binding assays / Bruno Boulanger, Viswanath Devanarayan, and Walthere Dewe -- Development and validation of ligand-binding assays for biomarkers / Jean W. Lee ... [et al.].
|
| 505 |
0 |
|
|a The use of commercial assay kits for PK/PD analysis in drug development / John L. Allinson and John D. Chappell -- Development and validation of immunogenicity assays for preclinical and clinical studies / Thomas H. Parish, Deborah Finco, and Viswanath Devanarayan -- Macromolecular reference standards for biotherapeutic pharmacokinetic analysis / Marie T. Rock and Stephen Keller -- Strategies for successful transfer of ligand-binding assays for successful validation and implementation in GXP environment / Wolfgang Klump and Howard Hill -- Application of automation in ligand-binding assays / Chris Morrow -- Documentation and regulatory compliance / C.T. Viswanathan and Jacqueline A. O'Shaughnessy -- Alternative and emerging methodologies in ligand-binding assays / Huifen F. Wang and John W.A. Findlay.
|
| 650 |
|
0 |
|a Radioligand assay.
|0 sh 85110769
|
| 650 |
|
0 |
|a Drug development.
|0 sh 97007921
|
| 650 |
1 |
2 |
|a Drug Design.
|0 D015195
|
| 650 |
2 |
2 |
|a Immunoassay.
|0 D007118
|
| 650 |
2 |
2 |
|a Ligands.
|0 D008024
|
| 650 |
2 |
2 |
|a Protein Binding.
|0 D011485
|
| 700 |
1 |
|
|a Khan, Masood N.
|0 n 2009183746
|
| 700 |
1 |
|
|a Findlay, John W. A.
|0 n 2009183747
|
| 938 |
|
|
|a Baker and Taylor
|b BTCP
|n BK0008377054
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 3114927
|
| 938 |
|
|
|a Ingram
|b INGR
|n 9780470041383
|
| 951 |
|
|
|a 1091607
|
| 994 |
|
|
|a C0
|b MPA
|
| 999 |
f |
f |
|i 2b7d0176-1f5d-5336-a908-b55fdb01e2db
|s f8625198-d114-5e38-9fc4-a8790c349756
|t 0
|
| 952 |
f |
f |
|p Can circulate
|a Massachusetts College of Pharmacy and Health Sciences
|b Boston Campus
|c MCPHS Boston Library
|d Boston Circulation
|t 0
|e RS425 .L54 2010
|h Library of Congress classification
|i Book
|m 0113401764262
|
